4//SEC Filing
CRAIG WILLIAM S 4
Accession 0001209191-09-042128
CIK 0001333248other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:32 PM ET
Size
9.0 KB
Accession
0001209191-09-042128
Insider Transaction Report
Form 4
Transactions
- Sale
Common stock
2009-08-25$11.00/sh−2,500$27,500→ 2,000 total - Exercise/Conversion
Stock option (right to buy)
2009-08-25−2,500→ 65,000 totalExercise: $0.40From: 2005-02-16Exp: 2015-02-15→ common stock (2,500 underlying) - Exercise/Conversion
Common stock
2009-08-25$0.40/sh+2,500$1,000→ 4,500 total
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2009.
- [F2]Not applicable to this transaction.
Documents
Issuer
CADENCE PHARMACEUTICALS INC
CIK 0001333248
Entity typeother
Related Parties
1- filerCIK 0001216988
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:32 PM ET
- Size
- 9.0 KB